|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1991-5-9
|
|
pubmed:abstractText |
We studied a group of patients with polymyalgia rheumatica (PMR) with or without biopsy-proven giant cell arteritis (GCA) in order to determine the prevalence of anticardiolipin antibodies (aCL) in these disorders and their association with vascular complications.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0002-9343
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
90
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
474-8
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:2012088-Aged,
pubmed-meshheading:2012088-Antibodies,
pubmed-meshheading:2012088-Cardiolipins,
pubmed-meshheading:2012088-Female,
pubmed-meshheading:2012088-Giant Cell Arteritis,
pubmed-meshheading:2012088-Humans,
pubmed-meshheading:2012088-Immunoglobulin G,
pubmed-meshheading:2012088-Immunoglobulin M,
pubmed-meshheading:2012088-Male,
pubmed-meshheading:2012088-Polymyalgia Rheumatica,
pubmed-meshheading:2012088-von Willebrand Factor
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications.
|
|
pubmed:affiliation |
Department of Internal Medicine, University of South Florida College of Medicine, Tampa.
|
|
pubmed:publicationType |
Journal Article
|
